Another lecture studying the presence of unique phenotypes in patients with NAFLD revealed that the Anthro-SBP (systolic blood pressure)-Glucose phenotype, referring to older individuals with higher BMI, SBP, and fasting blood glucose, had a higher all-cause mortality risk compared to the average phenotype, whereas the lipid-liver phenotype, referring to individuals with higher level of total cholesterol (TC), triglyceride, aspartate aminotransferase (AST), alanine aminotransferase (ALT), and gamma-glutamyl transferase (GGT), was not associated with higher all-cause mortality21. Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.